Bacterial profile, antimicrobial susceptibility patterns, and associated factors of community-acquired pneumonia among adult patients in Gondar, Northwest Ethiopia: A cross-sectional study
GHDx Entry last modified on: May 23, 2024
Data by Data Type
Infectious diseases in Poland in 2021
GHDx Entry last modified on: Apr 24, 2025
Epidemiology of falciparum malaria among residents of some rural and periurban communities in Ekiti State, Southwestern Nigeria
GHDx Entry last modified on: Apr 10, 2023
The prevalence of child maltreatment in Australia: findings from a national survey
GHDx Entry last modified on: May 23, 2024
Prevalence of birth injuries and associated factors among newborns delivered in public hospitals Addis Ababa, Ethiopia, 2021. Crossectional study
GHDx Entry last modified on: Apr 24, 2025
Measles Outbreak Investigation in Guradamole District of Bale Zone, South Eastern Ethiopia, 2021
GHDx Entry last modified on: Dec 12, 2023
Persistent depressive symptoms during COVID-19: a national, population-representative, longitudinal study of U.S. adults
GHDx Entry last modified on: Apr 10, 2023
Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study. Preprint
GHDx Entry last modified on: Apr 8, 2022
Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care
GHDx Entry last modified on: Mar 22, 2024
Pneumonia among Children Admitted to the Department of Medicine in a Tertiary Care Centre: A Descriptive Cross-sectional Study
GHDx Entry last modified on: Mar 22, 2024
Cost-effectiveness analysis of a supported employment intervention for people with mood and anxiety disorders in Denmark - the IPS-MA intervention
GHDx Entry last modified on: Mar 25, 2025
Prevalence of SARS-CoV-2 antibodies in Denmark 2020: results from nationwide, population-based sero-epidemiological surveys. Preprint
GHDx Entry last modified on: May 12, 2022
High Seroprevalence of SARS-CoV-2 Eight Months After Introduction in Nairobi, Kenya. Preprint
GHDx Entry last modified on: May 12, 2022
Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period. Preprint
GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence in Tamil Nadu through India’s two COVID waves: Evidence on antibody decline following infection and vaccination. Preprint
GHDx Entry last modified on: May 12, 2022
Seroprevalence of SARS-CoV-2 Infection Among Occupational Groups from Bucaramanga Metropolitan Area, Colombia. Preprint
GHDx Entry last modified on: Oct 5, 2022
Population-based seroprevalence of SARS-CoV-2 antibodies in a high-altitude setting in Peru. Preprint
GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 infections in kindergartens and associated households at the start of the second wave in Berlin, Germany – a cross sectional study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020
GHDx Entry last modified on: Jun 17, 2021
Sero-pravelence of SARS CoV-2 IgM and IgG Antibodies Amongst Blood Donors in Nigeria. Preprint
Epi surveillance
SARS-CoV-2 seroprevalence in Germany - a population based sequential study in five regions. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence in 12 Cities of India from July-December 2020. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Loreto, Peru. Preprint
GHDx Entry last modified on: Jun 18, 2021
Serial SARS-CoV-2 Seropravelence Studies in Delhi July-August 2020: Indications of Pre-existing Cross-reactive Antibodies and Implications for Disease Progression
GHDx Entry last modified on: Mar 14, 2022
Excess mortality in India from June 2020 to June 2021 during the COVID pandemic: death registration, health facility deaths, and survey data. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG at the epidemic peak in French Guiana. Preprint
GHDx Entry last modified on: Mar 14, 2022
The Burden of COVID-19 Infection in a Rural Tamil Nadu Community. Preprint
GHDx Entry last modified on: Mar 14, 2022
Anti-SARS-CoV-2 IgG seroprevalence study among blood donors in the Republic of Srpska: a 30-day survey
Studija seroprevalencije anti-SARS-CoV-2 IgG kod davalaca krvi u Republici Srpskoj: 30-dnevno ispitivanje
Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey
GHDx Entry last modified on: Feb 10, 2022
Rapid increase of SARS-CoV-2 seroprevalence during the 2020 pandemic year in the population of the city of Tirana, Albania. Preprint
GHDx Entry last modified on: May 12, 2022
Prevalence of SARS-CoV-2 in Karnataka, India
GHDx Entry last modified on: Mar 14, 2022
Dramatic Rise of Seroprevalence Rates of SARS-CoV-2 Antibodies among Healthy Blood Donors: The evolution of a Pandemic. Preprint
GHDx Entry last modified on: Oct 6, 2022
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic
GHDx Entry last modified on: Dec 11, 2023
Sero-prevalence of SARS-CoV-2 Antibody Among Adults in the General Population in Diredawa, Ethiopia. Preprint
GHDx Entry last modified on: Sep 13, 2022
Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults. Preprint
GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 antibody prevalence and symptoms in a local Austrian population. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence and characteristics of post-infection immunity in a general population cohort study in Catalonia, Spain. Preprint
GHDx Entry last modified on: May 12, 2022
A global survey of potential acceptance of a COVID-19 vaccine
GHDx Entry last modified on: Jun 17, 2021
Variation in SARS-CoV-2 seroprevalence in school-children across districts, schools and classes. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 in the West Bank region of Palestine: a cross-sectional seroepidemiological study
GHDx Entry last modified on: Mar 14, 2022
Increase in SARS-CoV-2 seroprevalence in healthy blood donors after the second wave of COVID-19 pandemic in South-Eastern Italy: evidence for asymptomatic young individuals as potential virus spreaders. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS CoV-2 Serosurvey in Addis Ababa, Ethiopia. Preprint
GHDx Entry last modified on: Mar 14, 2022
Fernando de Noronha: how an island controlled the community transmission of COVID-19 in Brazil. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 antibodies in an entirely PCR-sampled and quarantined community after a COVID-19 outbreak - the CoNAN study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil
GHDx Entry last modified on: Jun 17, 2021
Population-Based Random Survey for detection of COVID-19 Infection and Seroprevalence in Benghazi- Libya May/2020
GHDx Entry last modified on: Oct 3, 2022
The seroprevalence of SARS-CoV-2 IgG antibodies among asymptomatic blood donors in Saudi Arabia
GHDx Entry last modified on: Jun 17, 2021
Anti-SARS-CoV-2 IgG antibodies in adolescent students and their teachers in Saxony, Germany (SchoolCoviDD19): very low seropraevalence and transmission rates. Preprint
GHDx Entry last modified on: Mar 14, 2022
Positive Rate of Serology and RT-PCR for COVID-19 between Community Residents and Healthcare Workers in Wuhan, China
GHDx Entry last modified on: Mar 14, 2022
Pages
Subscribe
